Gilead Sciences (GILD) Dividends Paid - Common (2009 - 2026)
Gilead Sciences (GILD) posted Dividends Paid - Common of $1.0 billion for Q1 2026, up 4.63% quarter-over-quarter from $994.0 million in Q4 2025, and up 3.59% year-on-year from $1.0 billion in Q1 2025.
Gilead Sciences (GILD) Dividends Paid - Common (2009 - 2026) Analysis & Trends
Gilead Sciences (GILD) has reported Dividends Paid - Common for 13 consecutive years, with $1.0 billion the latest figure, recorded in Q1 2026.
- Dividends Paid - Common for Q1 2026 came in at $1.0 billion, up 3.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.0 billion (up 2.39% YoY), and the FY2025 annual result was $4.0 billion, up 2.17% from the prior year.
- Dividends Paid - Common was $1.0 billion for Q1 2026 at Gilead Sciences, up from $994.0 million in the prior quarter.
- Over five years, Dividends Paid - Common peaked at $1.0 billion in Q1 2026 and troughed at $931.0 million in Q4 2022.
- Average Dividends Paid - Common over 5 years is $969.8 million, with a median of $973.0 million recorded in 2024.
- Year-over-year, Dividends Paid - Common climbed 4.14% in 2022 and grew 1.14% in 2024.
- Over 5 years, Dividends Paid - Common stood at $931.0 million in 2022, then increased by 1.5% to $945.0 million in 2023, then increased by 2.96% to $973.0 million in 2024, then rose by 2.16% to $994.0 million in 2025, then climbed by 4.63% to $1.0 billion in 2026.
- Per Business Quant data, the three most recent Dividends Paid - Common figures were $1.0 billion in Q1 2026, $994.0 million in Q4 2025, and $995.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 1.55 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 3.13 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 3.09 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -3.29 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 2.11 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 1.36 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 1.04 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 2.45 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.04 Bn |
| Mar 31, 2026 | 1.04 Bn |
| Dec 31, 2025 | 994.00 Mn |
| Dec 31, 2025 | 994.00 Mn |
| Sep 30, 2025 | 995.00 Mn |
| Sep 30, 2025 | 995.00 Mn |
| Jun 30, 2025 | 997.00 Mn |
| Jun 30, 2025 | 997.00 Mn |
| Mar 31, 2025 | 1.00 Bn |
| Mar 31, 2025 | 1.00 Bn |
| Dec 31, 2024 | 973.00 Mn |
| Dec 31, 2024 | 973.00 Mn |
| Sep 30, 2024 | 977.00 Mn |
| Sep 30, 2024 | 977.00 Mn |
| Jun 30, 2024 | 978.00 Mn |
| Jun 30, 2024 | 978.00 Mn |
| Mar 31, 2024 | 980.00 Mn |
| Mar 31, 2024 | 980.00 Mn |
| Dec 31, 2023 | 945.00 Mn |
| Dec 31, 2023 | 945.00 Mn |